Real-time enrollment status for this idiopathic short stature clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 9:58 AM UTC
| NCT Number | NCT06382155 |
| Recruiting Status | Recruiting |
| Condition | Idiopathic Short Stature |
| Phase | PHASE2 |
| Target Enrollment | 100 participants |
| Active Locations | 35 sites in the US |
| Sponsor | BioMarin Pharmaceutical |
| Last Updated on CT.gov | May 22, 2026 (May 22, 2026) |
As of July 17, 2026: Clinical trial NCT06382155 is currently recruiting participants. This phase2 study for idiopathic short stature is actively seeking new participants at 35 locations across the United States. The study is sponsored by BioMarin Pharmaceutical. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06382155 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 35 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06382155 was last updated May 22, 2026 (May 22, 2026). HelloStudys verifies this status automatically.